Carmignac Gestion increased its stake in Chemocentryx Inc (CCXI) by 60.54% based on its latest 2019Q1 regulatory filing with the SEC. Carmignac Gestion bought 741,210 shares as the company’s stock rose 15.42% with the market. The institutional investor held 1.97M shares of the health care company at the end of 2019Q1, valued at $27.30M, up from 1.22 million at the end of the previous reported quarter. Carmignac Gestion who had been investing in Chemocentryx Inc for a number of months, seems to be bullish on the $510.82M market cap company. The stock decreased 0.68% or $0.06 during the last trading session, reaching $8.8. About 64,014 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 11.16% since July 11, 2018 and is uptrending. It has outperformed by 6.73% the S&P500. Some Historical CCXI News: 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress; 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 09/05/2018 – ChemoCentryx 1Q Loss/Shr 19c; 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80
Cwh Capital Management Inc increased its stake in Borgwarner Inc (BWA) by 39.8% based on its latest 2019Q1 regulatory filing with the SEC. Cwh Capital Management Inc bought 32,655 shares as the company’s stock declined 8.40% while stock markets rallied. The institutional investor held 114,710 shares of the o.e.m. company at the end of 2019Q1, valued at $4.41 million, up from 82,055 at the end of the previous reported quarter. Cwh Capital Management Inc who had been investing in Borgwarner Inc for a number of months, seems to be bullish on the $8.00 billion market cap company. The stock decreased 1.40% or $0.55 during the last trading session, reaching $38.68. About 398,742 shares traded. BorgWarner Inc. (NYSE:BWA) has declined 27.44% since July 11, 2018 and is downtrending. It has underperformed by 31.87% the S&P500. Some Historical BWA News: 10/04/2018 – BorgWarner Receives 2018 Automotive News PACE Award for Innovative Electric Motor Technology; 21/05/2018 – BorgWarner to Host Investor Day on September 18, 2018; 26/04/2018 – BorgWarner Sees 2Q EPS $1.09-EPS $1.11; 26/04/2018 – BorgWarner 1Q Net $225M; 26/04/2018 – BORGWARNER INC – FOREIGN CURRENCIES ARE EXPECTED TO INCREASE 2018 SALES BY $405 MLN, DUE TO APPRECIATION OF EURO AND CHINESE YUAN; 05/04/2018 – BorgWarner Closes Above 50-Day Moving Average: Technicals; 27/04/2018 – BorgWarner Closes Below 200-Day Moving Average: Technicals; 29/03/2018 – BorgWarner Closes Above 200-Day Moving Average: Technicals; 13/03/2018 – BorgWarner: Technology Available in Growing Line-Up of Ford Vehicles With 8-Speed Transmissions; 26/04/2018 – BorgWarner 1Q Adj EPS $1.10
More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Nasdaq.com which released: “Takeover of little-known Baoshang casts doubt over other small Chinese banks – Nasdaq” on May 30, 2019, also Seekingalpha.com with their article: “ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q1 2019 Results – Earnings Call Transcript – Seeking Alpha” published on May 06, 2019, Benzinga.com published: “Benzinga’s Top Upgrades, Downgrades For March 27, 2019 – Benzinga” on March 27, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Globenewswire.com and their article: “ChemoCentryx to Present at the 8th Annual SVB Leerink Global Healthcare Conference – GlobeNewswire” published on February 20, 2019 as well as Globenewswire.com‘s news article titled: “Presentations at ASN Kidney Week 2018 Highlight ChemoCentryx Platform in Treatment of ANCA-Associated Vasculitis and Focal Segmental Glomerulosclerosis (FSGS) – GlobeNewswire” with publication date: October 25, 2018.
Carmignac Gestion, which manages about $8.58 billion US Long portfolio, decreased its stake in Carrizo Oil & Gas Inc (NASDAQ:CRZO) by 180,634 shares to 514,965 shares, valued at $6.42M in 2019Q1, according to the filing. It also reduced its holding in Grupo Supervielle Sa by 200,222 shares in the quarter, leaving it with 1.53M shares, and cut its stake in 58.Com Inc (NYSE:WUBA).
Investors sentiment increased to 1.44 in Q1 2019. Its up 0.51, from 0.93 in 2018Q4. It is positive, as 12 investors sold CCXI shares while 27 reduced holdings. 22 funds opened positions while 34 raised stakes. 33.34 million shares or 22.88% more from 27.13 million shares in 2018Q4 were reported. Aqr Mgmt Limited Company reported 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Bankshares Of America Corp De owns 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 92,817 shares. Jacobs Levy Equity Mgmt Inc owns 51,190 shares or 0.01% of their US portfolio. 74 are owned by Pnc Fincl Ser Group. Gp One Trading Limited Partnership owns 9,979 shares or 0% of their US portfolio. Point72 Asset Management Lp holds 400,000 shares. Meeder Asset Mngmt holds 0.01% or 6,176 shares in its portfolio. California Employees Retirement reported 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Legal & General Group Inc Plc holds 5,183 shares or 0% of its portfolio. Franklin Resource Inc holds 0.01% or 1.38 million shares in its portfolio. Spark Mgmt Llc reported 0.12% stake. Citadel Advsrs Limited Liability invested in 26,133 shares or 0% of the stock. Tiaa Cref Invest Management Limited Co holds 0% or 288,597 shares in its portfolio. Raymond James & Assocs holds 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 13,874 shares. Zebra Capital Mngmt Ltd Llc reported 12,853 shares.
Since January 22, 2019, it had 0 insider buys, and 1 insider sale for $457,747 activity.
More notable recent BorgWarner Inc. (NYSE:BWA) news were published by: Finance.Yahoo.com which released: “Should We Be Delighted With BorgWarner Inc.’s (NYSE:BWA) ROE Of 21%? – Yahoo Finance” on July 03, 2019, also Benzinga.com with their article: “BorgWarner Issues Soft Second Quarter Guidance Despite Beating First Quarter Expectations – Benzinga” published on April 25, 2019, Finance.Yahoo.com published: “Some BorgWarner (NYSE:BWA) Shareholders Are Down 31% – Yahoo Finance” on May 03, 2019. More interesting news about BorgWarner Inc. (NYSE:BWA) were released by: Prnewswire.com and their article: “BorgWarner R2S® Takes Turbocharging to New Levels of Fuel Efficiency – PRNewswire” published on July 09, 2019 as well as Seekingalpha.com‘s news article titled: “Wall Street Brunch – Seeking Alpha” with publication date: July 07, 2019.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.